Find Clinical Trial

A study to assess the release profiles from fixed combination tablets (gliclazide MR/metformin)


← Back
Study Phase

Phase 1

Therapeutic Area

Metabolism

IndicationDiabetes - Type II
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active substance/
Medical device

GLICLAZIDE, METFORMINE,
S005720

Active Substance CodeS005720
Protocol CodePKH-05720-001
ISRCTN CodeISRCTN41840459


Documents and links

Results summary READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2020 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility